The platform was built specifically for people serious about peptide research, with protocols informed by clinical literature and real-world experience from thousands of users
Effects of switching from liraglutide or dulaglutide to subcutaneous semaglutide on glucose metabolism and treatment satisfaction in patients with type 2 diabetes: protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
Reading Time: 6 minutes Ozempic made a splashy debut in 2017 with a catchy jingle and celebrity following, and Mounjaro came onto the scene five years later as another impressive type 2 diabetes medication that delivers impactful glucose management results along with significant weight loss
The waitlist is free, with no commitment and no payment details required
We've guided hundreds of patients through medically supervised weight loss protocols